CV Shariat_AKH - Vienna OMI

O P E N P R O T O C O L S• Phase I trial of adenoviral mediated suicide gene therapy with hsv-tk followed 2000by intravenous administration of ganciclovir in patients with locally advancedand refractory superficial bladder cancerGCRC, IRB, IND and FDA ProtocolBaylor College of Medicine, Principal Investigators: Shariat S. and Lerner S.• Phase I/II trial of caspase-induced apoptotic prostate cancer cell kill using a gene 2001therapeutic methodGCRC, IRB, IND and FDA ProtocolBaylor College of Medicine, Principal Investigators: Shariat S., Slawin K., Spencer D.• Microarray analysis of zone-specific gene expression in response to medical therapy 2000for BPHBaylor College of Medicine, Principal Investigators: Shariat S., Slawin K., Spencer D.• Pre-clinical and human applications of suicide gene therapy for bladder cancer 2000Bladder cancer National Cancer Institute Specialized Program of Research Excellence.Baylor College of Medicine, Principal Investigators: Shariat S. and Lerner S.• Prospective randomization of patients treated with radical cystectomy to adjuvant 2008chemotherapy based on biomarker panel statusGCRC and IRB ProtocolUniversity of Texas Southwestern Dallas, Principal Investigators: Shariat S. and Lotan Y.• Prospective evaluation of biomarker panel in patients with high-risk non-muscle 2010invasive bladder cancerGCRC and IRB ProtocolUniversity of Texas Southwestern Dallas, Principal Investigator: Lotan Y.Weill Cornell Medical Center, Principal Investigator: Shariat S.• Discovery of biomarkers for bladder and kidney cancer 2010IRB No. 1007011131Weill Cornell Medical Center, Principal Investigators: Scherr D. and Shariat S.• Use of multiphoton microscopy in the diagnosis of cancer 2010IRB No. 0506007919Weill Cornell Medical Center, Principal Investigator: Scherr D., Co-Investigator: Shariat S.• Rapid multiplexed detection of pathogens with DNA nanobarcodes 2010IRB No. 1006011064Weill Cornell Medical Center, Principal Investigator: Scherr D., Co-Investigator: Shariat S.• Development of the Cornell prostate cancer biobank for the National Cancer 2010Institute – Early Detection Research Network (NCI-EDRN) for prostate cancerbiomarker researchIRB No. 0711009545Weill Cornell Medical Center, Principal Investigator: Scherr D., Co-Investigator: Shariat S.• Molecular profiling of bladder cancer 2011IRB No. 1011011386Weill Cornell Medical Center, Principal Investigator: Shariat S.• Optical coherence tomography as an adjunct to white light cystoscopy for intravesical 2010real time imaging and staging of bladder cancerIRB No. 0807009899Weill Cornell Medical Center, Principal Investigator: Scherr D., Co-Investigator: Shariat S.• Database of urological malignancies 2010www.vienna-omi.at 28.08.2013